Novo teams up with VIVO Capital for biopharma expansion
Novo Holdings has announced that it wil co-lead with Vivo Capital the over-subscribed US$200-million Series A and Crossover round in Esco Lifesciences Group (“Esco”), a leading provider of life sciences …
Novo teams up with VIVO Capital for biopharma expansion Read More